Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients
Open Access
- 12 January 2023
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (2) , 278-283
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant RecipientsNew England Journal of Medicine, 2021
- Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primatesScience, 2021
- Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case SeriesAnnals of Internal Medicine, 2021
- SARS-CoV-2 Variants in Patients with ImmunosuppressionNew England Journal of Medicine, 2021
- Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant RecipientsTransplantation, 2021
- COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapiesJournal for ImmunoTherapy of Cancer, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Outcomes of COVID‐19 in solid organ transplant recipients: A matched cohort studyTransplant Infectious Disease, 2021
- A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2Nature Communications, 2021
- A simple protein-based surrogate neutralization assay for SARS-CoV-2JCI Insight, 2020